Trial | NCT01425411  Report issue

Official Title

Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    valsartan ...

  • Study Participants

    38
The study hypothesis: Valsartan as an angiotensin II receptor blocker treatment has beneficial effects on both midwall mechanics and myocardial functions in hypertensive patients with Left ventricular hypertrophy.
Study Started
Nov 30
2006
Primary Completion
Nov 30
2008
Study Completion
Nov 30
2008
Last Update
Aug 30
2011
Estimate

Drug valsartan

80/160 mg dosage of valsartan or 160+12,5 mg valsartan+hydrochlorothiazide combination, once a day, for six months

  • Other names: Diovan 80 mg, Diovan 160 mg, Co-diovan 160/12,5 mg

Valsartan treatment Experimental

Criteria 

Inclusion Criteria:

hypertension with left ventricular hypertrophy

Exclusion Criteria:

clinical or laboratory evidence of secondary hypertension
heart failure
ischemic heart disease
valvular heart disease
arrhythmias
peripheral vascular disease
chronic obstructive pulmonary disease
neurologic disorders
diabetes mellitus
renal dysfunction
notable systemic disease
No Results Posted